Drug Registration Commission: Next year’s vaccines



[ad_1]

Miroslav Savic, member of the Medicines Registration Commission of the Agency for Medicines and Health Products, expressed his conviction that in the first quarter of next year, a good part of the population of Europe will have a vaccine against the coronavirus and that Serbia it will be part of that process. “.

Savic told “Danas” that when it comes to the registration of vaccines against the coronavirus, nothing happens in Serbia that does not happen in the rest of the world, recalling that there is a mechanism for urgent approval of the vaccine in the US Drug Agency. (FDA).

“Both globally and in Serbia, vaccine registration procedures are carried out within the existing legal framework,” Savic said.

He said that all the vaccines currently being discussed are “relevant” and that there will be more than two or three vaccines for use in Europe.

“I think that vaccines that have not been developed in Western European countries will also participate in the vaccination program in Western Europe, because there is a difference between individual vaccines in coverage, that is, not all vaccines will be approved for all categories of the population “, emphasized Savic.

The Serbian Drug Agency has so far received documentation for the Pfizer-Biontek vaccine, and it was said that 20 doses of the “Sputnik V” vaccine arrived in Serbia for laboratory testing, but Savic could not say if it was for the “Sputnik V “. The accompanying documentation related to clinical trials has also arrived.

Read more about kovid-19 and the consequences of the pandemic in the country and the world on the page. Coronavirus.



[ad_2]